Dr. Reddy's Laboratories is a pharmaceutical company. Co. provides medicines through its business segments: Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients, which is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates; and Proprietary Products, which focuses on the research and development of differentiated formulations. The RDY stock yearly return is shown above.
The yearly return on the RDY stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2017 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the RDY annual return calculation with any dividends reinvested as applicable (on ex-dates).
|